Straus Daniel E's Form 4 filing
P3 Health Partners Inc. (PIII) · filed Aug 12, 2026
- Accession no.
- 0001104659-26-094925
- Filed
- Aug 12, 2026, 4:30 PM ET
- Trade date
- Aug 10, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions. Open-market sales total $823.9K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Straus Daniel ECIK 0000940344 | 10% Owner |
| Hudson Vegas Investment Manager, LLCCIK 0001900111 | 10% Owner |
| Hudson Vegas Investment SPV, LLCCIK 0001900112 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 10, 2026 | Class A Common Stock | SSaleDisposed | −1,041 | $13.38F1 | −$13,928.58 | 48,959 | Direct | |
| Aug 10, 2026 | Class A Common Stock | SSaleDisposed | −19,074 | $16.05F2 | −$306,137.7 | 29,885 | Direct | |
| Aug 10, 2026 | Class A Common Stock | SSaleDisposed | −29,885 | $16.86F3 | −$503,861.1 | 0 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
The price reported is a weighted average price. Shares were sold in multiple transactions at prices ranging from $13.00 to $13.61, inclusive. The reporting persons undertake to provide to the Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
Referenced by the price of 1 transaction in Table I.
- F2
The price reported is a weighted average price. Shares were sold in multiple transactions at prices ranging from $16.00 to $16.24, inclusive. The reporting persons undertake to provide to the Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
Referenced by the price of 1 transaction in Table I.
- F3
The price reported is a weighted average price. Shares were sold in multiple transactions at prices ranging from $16.25 to $17.24, inclusive. The reporting persons undertake to provide to the Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
Referenced by the price of 1 transaction in Table I.